Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea

Inclusion Criteria: * Male or female who is at least 18 years of age. * Clinical diagnosis of stable moderate to severe erythematotelangiectatic rosacea. * CEA (clinician's erythema assessment) score greater than or equal to 3 at Screening and on Treatment visit at baseline. * PSA (patient self assessment) score of greater than or equal to 3 at Screening and on Treatment visit at baseline. * Presence of 2 or fewer inflammatory facial lesions. Exclusion Criteria: * History of Raynaud's Syndrome, glaucoma, orthostatic hypotension, thromboangiitis obliterans, cerebral or coronary insufficiency, or depression. * History of refractive surgery such as photorefractive keratectomy. * The subject is being treated with monoamine oxidase (MAO) inhibitor, anti-depressants, barbiturates, opiates, sedatives, systemic anesthetics, alpha-agonists, beta blockers, antihypertensive agents, cardiac glycosides, or systemic anticoagulants. * The subject is currently enrolled in an investigational drug or device study or participated in such a study in the past 3 months prior to enrollment and is still in the exclusion period on the day of the Treatment visit.